Approval · Notice of Compliance 33121 · 2024
CELLCEPT: Notice of Compliance 33121
Issued April 25, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33121
- Date
- April 25, 2024
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of an alternative grade for soybean lecithin excipient
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CELLCEPT | Not yet assigned | — |
Medicinal ingredients
- MYCOPHENOLATE MOFETIL 200 MG per ML